Diastereomers of the brominated flame retardant 1,2-dibromo-4-(1,2 dibromoethyl)cyclohexane induce androgen receptor activation in the HepG2 hepatocellular carcinoma cell line and the LNCaP prostate cancer cell line

Environmental Health Perspectives

Volumn 117, Issue 12, 2009, Pages 1853-1859

  Khalaf, Hazem ^a   Larsson, Anders ^a   Berg, Håkan ^a   McCrindle, Robert ^b   Arsenault, Gilles ^b   Olsson, Per Erik ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

^b Canada N1G 3M5   (Canada)

Author keywords

Androgen; Brominated flame retardant; Endocrine disruptor

Indexed keywords

1,2 DIBROMO 4 (1,2 DIBROMOETHYL)CYCLOHEXANE; AMINO ACID; ANDROGEN RECEPTOR; CYCLOHEXANE DERIVATIVE; FLAME RETARDANT; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL STRAIN LNCAP; CONTROLLED STUDY; DIASTEREOISOMER; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOASSAY; RECEPTOR BINDING;

CELL LINE, TUMOR; CYCLOHEXANES; ENDOCRINE DISRUPTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAME RETARDANTS; HEP G2 CELLS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STEREOISOMERISM;

ANIMALIA; AVES; DANIO RERIO; DELPHINAPTERUS LEUCAS;

EID: 75349109314     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901065     Document Type: Article

References (42)

1. Anway MD, Leathers C, Skinner MK. 2006. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 147(12):5515-5523.
2. Anway MD, Rekow SS, Skinner MK. 2008. Transgenerational epigenetic programming of the embryonic testis transcriptome. Genomics 91(1):30-40.
3. Araki N, Ohno K, Nakai M, Takeyoshi M, Iida M. 2005. Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen cells. Toxicol In Vitro 19(6):831-842.
4. Arsenault G, Lough A, Marvin C, McAlees A, McCrindle R, MacInnis G, et al. 2008. Structure characterization and thermal stabilities of the isomers of the brominated flame retardant 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane. Chemosphere 72(8):1163-1170.
5. Berry SJ, Coffey DS, Walsh PC, Ewing LL. 1984. The development of human benign prostatic hyperplasia with age. J Urol 132(3):474-479.
6. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, et al. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 54(1):138-153.
7. Bonefeld-Jørgensen EC, Long M, Hofmeister MV, Vinggaard AM. 2007. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect 115(suppl 1):69-76.
8. Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA, et al. 1999. Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 69(1-6):307-313.
9. Cabeza M, Flores M, Bratoeff E, de la Pena A, Mendez E, Ceballos G. 2004. Intracellular Ca2+ stimulates the binding to androgen receptors in platelets. Steroids 69(11-12):767-772.
10. Carson C III, Rittmaster R. 2003. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 61(4 suppl 1):2-7.
11. Ellis RJ, van den Heuvel MR, Bandelj E, Smith MA, McCarthy LH, Stuthridge TR, et al. 2003. In vivo and in vitro assessment of the androgenic potential of a pulp and paper mill effluent. Environ Toxicol Chem 22(7):1448-1456.
12. Elzeinova F, Novakova V, Buckiova D, Kubatova A, Peknicova J. 2008. Effect of low dose of vinclozolin on reproductive tract development and sperm parameters in CD1 outbred mice. Reprod Toxicol 26(3-4):231-238.
13. Fang H, Tong W, Branham WS, Moland CL, Dial SL, Hong H, et al. 2003. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol 16(10):1338-1358.
14. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, et al. 1994. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 54(11):2861-2864.
15. Gauthier LT, Potter D, Hebert CE, Letcher RJ. 2009. Temporal trends and spatial distribution of non-polybrominated diphenyl ether flame retardants in the eggs of colonial populations of Great Lakes herring gulls. Environ Sci Technol 43(2):312-317.
16. Hossain MS, Larsson A, Scherbak N, Olsson PE, Orban L. 2008. Zebrafish androgen receptor: isolation, molecular, and biochemical characterization. Biol Reprod 78(2):361-369.
17. Kojima H, Katsura E, Takeuchi S, Niiyama K, Kobayashi K. 2004. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ Health Perspect 112:524-531.
18. Larsson A, Eriksson LA, Andersson PL, Ivarson P, Olsson PE. 2006. Identification of the brominated flame retardant 1,2-dibromo-4-(1,2- dibromoethyl)cyclohexane as an androgen agonist. J Med Chem 49(25):7366-7372.
19. Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, et al. 1999. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48(1):55-66.
20. Lenasi H, Breskvar K. 2004. Specific interactions of steroids, arylhydrocarbons and flavonoids with progesterone receptors from the cytosol of the fungus Rhizopus nigricans. J Steroid Biochem Mol Biol 91(4-5):273-284.
21. McGregor DB, Brown AG, Howgate S, McBride D, Riach C, Caspary WJ. 1991. Responses of the L5178Y mouse Lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ Mol Mutagen 17(3):196-219.
22. National Center for Biotechnology Information. 2009. GenBank Overview. Available: http://www.ncbi.nlm.nih.gov/Genbank/ [accessed 26 October 2009].
23. Nyholm JR, Norman A, Norrgren L, Haglund P, Andersson PL. 2008. Maternal transfer of brominated flame retardants in zebrafish (Danio rerio). Chemosphere 73(2):203-208.
24. Olsson PE, Berg AH, von Hofsten J, Grahn B, Hellqvist A, Larsson A, et al. 2005. Molecular cloning and characterization of a nuclear androgen receptor activated by 11-ketotestosterone. Reprod Biol Endocrinol 3:37; doi:10.1186/1477-7827-3-37 [Online 17 August 2005].
25. PDB (Protein Data Bank). 2009. 1e3g. Available: http://www.pdb.org/pdb/ explore/explore.do?structureId=1E3G [accessed 23 October 2009].
26. Pillon A, Boussioux AM, Escande A, Aït-Aïssa S, Gomez E, Fenet H, et al. 2005. Binding of estrogenic compounds to recombinant estrogen receptor-α: application to environmental analysis. Environ Health Perspect 113:278-284.
27. Santillo D, Labounskaia I, Stringer RL, Johnston PA. 1997. Report on the Analysis of Industrial Wastewaters from the Frutarom VCM/PVC Plant, near Haifa, Israel, and Adjacent Shoreline Sediments for Organic Contaminants. Technical Note03/97. Exeter, UK:Greenpeace Research Laboratories. Available: http://www.greenpeace.to/publications/TN-03-97.pdf [accessed 27 October 2009].
28. Scippo ML, Argiris C, Van De Weerdt C, Muller M, Willemsen P, Martial J, et al. 2004. Recombinant human estrogen, androgen and progesterone receptors for detection of potential endocrine disruptors. Anal Bioanal Chem 378(3):664-669.
29. Simon S, Mueller SO. 2006. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context. Toxicology 220(2-3):90-103.
30. Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D. 2008. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS ONE 3(11):e3745; doi:10.1371/journal.pone.0003745 [Online 18 November 2008].
31. Sohoni P, Sumpter JP. 1998. Several environmental oestrogens are also anti-androgens. J Endocrinol 158(3):327-339.
32. Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B. 2005. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol Sci 83(1):136-148.
33. Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, et al. 1999. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res 59(11):2511-2515.
34. Tomy GT, Pleskach K, Arsenault G, Potter D, McCrindle R, Marvin CH, et al. 2008. Identification of the novel cycloaliphatic brominated flame retardant 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane in Canadian Arctic beluga (Delphinapterus leucas). Environ Sci Technol 42(2):543-549.
35. U.S. EPA. 2000. Waste Minimization Prioritization Tool: Background Document for the Tier PBT Chemical List. Appendix A: WMPT Summary Spreadsheet. Washington, DC:U.S. Environmental Protection Agency.
36. Veldscholte J, Berrevoets CA, Zegers ND, van der Kwast TH, Grootegoed JA, Mulder E. 1992. Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry 31(32):7422-7430.
37. Verrijdt G, Schauwaers K, Haelens A, Rombauts W, Claessens F. 2002. Functional interplay between two response elements with distinct binding characteristics dictates androgen specificity of the mouse sex-limited protein enhancer. J Biol Chem 277(38):35191-35201.
38. Viswanath G, Halder S, Divya G, Majumder CB, Roy P. 2008. Detection of potential (anti)progestagenic endocrine disruptors using a recombinant human progesterone receptor binding and transactivation assay. Mol Cell Endocrinol 295(1-2):1-9.
39. Wang LG, Liu XM, Kreis W, Budman DR. 1997. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells. Cancer Res 57(4):714-719.
40. Westerink WM, Stevenson JC, Schoonen WG. 2008. Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition. Arch Toxicol 82(12):909-921.
41. Xu LC, Sun H, Chen JF, Bian Q, Qian J, Song L, et al. 2005. Evaluation of androgen receptor transcriptional activities of bisphenol A, octylphenol and nonylphenol in vitro. Toxicology 216(2-3):197-203.
42. Zeiger M, Haag R, Hockel J, Schrenk D, Schmitz HJ. 2001. Inducing effects of dioxin-like polychlorinated biphenyls on CYP1A in the human hepatoblastoma cell line HepG2, the rat hepatoma cell line H4IIE, and rat primary hepatocytes: comparison of relative potencies. Toxicol Sci 63(1):65-73.